SCIENTIFIC STUDIES

1. 2-Methyl-3-Phenylaminomethylquinolin-4-One As Potential Antidepressant With Nootropic Properties
2. A Brief Introduction Of Docosahexaenoic Acid And Its Nootropic Effect [J]
3. A Carbon-13 Nmr Spin-Lattice Relaxation Study Of The Molecular Conformation Of The Nootropic Drug 2-Oxopyrrolidin-1-Ylacetamide
4. A Clinical And Neurophysiological Trial On Nootropic Drugs In Patients With Mental Decline.
5. A Combination Of Nootropic Ingredients (Caf+) Is Not Better Than Caffeine In Improving Cognitive Functions
6. A Comparative Analysis Of The Effect Of Nootropic Preparations With Different Chemical Structures On The Failure Of The Escape Reaction In Rats
7. A Comparative Study Of The Nootropic Properties Of Piracetam And Oxiracetam
8. A Natural And Broad Spectrum Nootropic Substance For Treatment Of Sdat–The Ginkgo Biloba Extract.
9. A Natural And Broad—Spectrum Nootropic Substance For Treatment Of Sdat—The Ginkgo Biloba Extract
10. A New Method For Testing The Psychopharmacologic Pupil Oscillation Hypothesis Following Administration Of A Nootropic Substance
11. A New Nootropic Aniracetam: Its Prevention Of Scopolamine-Induced Retrograde Amnesia And Its Possible Action Mechanisms
12. A New Substance With Nootropic Activity–N-5 (Hydroxynicotinoyl)-L-Glutamic Acid
13. A Nootropic Adrenocorticotropin Analog 4-10-Semax (L5 Years Experience In Its Design And Study)
14. A Novel Effect Of Bifemelane, A Nootropic Drug, On Intracellular Ca2+ Levels In Rat Cerebral Astrocytes
15. A Practical Synthesis Of The Chinese” Nootropic ” Agent Huperzine A: A Possible Lead In The Treatment Of Alzheimer’S Disease
16. A Simple & Effective Pre-Workout Nootropic Stack That Won’T Break The Bank
17. A Simplified Route To A Key Intermediate In The Synthesis Of The Chinese Nootropic Agent Huperzine A
18. A Study Of Nootropic Drugs For Anti-Anxiety Action.
19. A Study On Nootropic Activity Of Methanolic Extract Of Brassica Oleraceae Var. Caulorapa Bulb In Rodents
20. A Study To Evaluate The Effect Of Nootropic Drug—Piracetam On Dna Damage In Leukocytes And Macrophages
21. A Traditional Approach To Herbal Nootropic Agents: An Overview
22. A Weird Concept With Unusual Fate: Nootropic Drug
23. Acetylcholinesterase Inhibition In Cognition-Relevant Brain Areas Of Mice Treated With A Nootropic Amazonian Herbal (Marapuama)
24. Acetylcholinesterase Inhibitory Activity Of Thai Traditional Nootropic Remedy And Its Herbal Ingredients.
25. Action Mechanism Study Of The Nootropic Peptide Semax For The Development Of New Therapeutic Solutions
26. Action Of Nootropic Drugs On Transcallosal Responses In Rats
27. Activity Guided Synthesis And Sar Study Of Flavonols As Nootropic Agents
28. Adaptogenic And Nootropic Activities Of Aqueous Extract Of Carum Carvi Linn.(Caraway) Fruit: An Experimental Study In Wistar Rats
29. Adaptogenic And Nootropic Activities Of Aqueous Extract Of Vitis Vinifera (Grape Seed): An Experimental Study In Rat Model
30. Adaptogenic And Nootropic Activities Of Aqueous Extracts Of Carum Carvi Linn (Caraway) Fruit: An Experimental Study In Wistar Rats
31. Adaptogenic And Nootropic Activity Of Mimosa Pudica In Albino Wistar Rats
32. Age-Related Changes Of Cyclic Amp Phosphodiesterase Activity In Rat Brain Regions And A New Phosphodiesterase Inhibitor–Nootropic Agent Adafenoxate.
33. Age-Related Changes Of The Effects Of A Group Of Nootropic Drugs On The Content Of Rat Brain Biogenic Monoamines.
34. Age-Related Differences In Memory And In The Memory Effects Of Nootropic Drugs.
35. Agonist-And Subunit-Dependent Potentiation Of Glutamate Receptors By A Nootropic Drug Aniracetam
36. Allosteric Potentiation Of Quisqualate Receptors By A Nootropic Drug Aniracetam.
37. Along-Term-Potentiation-Like’Facilitation Of Hippocampal Synaptic Transmission Induced By The Nootropic Nefiracetam
38. Alpha Brain Review: Onnit’S Old-School Nootropic Shows Its Age
39. Ameliorative Influence Of A Nootropic Drug On Motor Activity Of Rats After Bilateral Carotid Artery Occlusion
40. Amino-Acid Composition And Nootropic Properties Of Polynoophyt
41. Amycenone, A Nootropic Found In Hericium Erinaceum
42. An Appraisal Of Medhya Rasayana (Nootropic Herbs) In Present Scenario
43. An Egg Yolk’S Phospholipid-Pennyroyal Nootropic Nanoformulation Modulates Monoamino Oxidase-A (Mao-A) Activity In Sh-Sy5Y Neuronal Model
44. An Experimental Study Of Ethanolic Seed Extract Of Vigna Mungo Linn. For Nootropic Activity On Albino Rats
45. An Investigation Into The Acute Nootropic Effects Of Hypericum Perforatum L.(St. John’S Wort) In Healthy Human Volunteers
46. Analysis Of Nootropic Used In Our Hospital During 2008-2010
47. Analysis Of Pharmaceutical Market Of Nootropic Drugs In Ukraine
48. Analytic Evaluation Of Potential Nootropic Agents
49. Analyzing Nootropic Effect Of Phyllanthus Reticulatus Poir. On Cognitive Functions, Brain Antioxidant Enzymes And Acetylcholinesterase Activity Against …
50. Antagonism Of Zn2+ On Nootropic Action Of Piracetam In Mice
51. Anticonvulsant And Neuroprotective Effects Of The Novel Nootropic Agent Nefiracetam On Kainic Acid-Induced Seizures In Rats
52. Anticonvulsant Properties Of The Novel Nootropic Agent Nefiracetam In Seizure Models Of Mice And Rats
53. Antidepressant Activities Of Web 1881, A New Nootropic Agent.
54. Antidepressant, Psychostimulant, And Nootropic Effects Of Major And Trace Element Composition
55. Antiepileptic Effects Of Nootropic Agent, Nefiracetam.-In Vivo Study Of Epileptic Mutant, El Mice.
56. Antihyperglycemic, Antistress And Nootropic Activity Of Roots Of Rubia Cordifolia Linn
57. Antihypoxic Activity Of 2-Methyl-3-Phenylaminomethylquinolin-4 Of The Perspective Antidepressant With Nootropic …
58. Antihypoxic Effect Of 3-Hydroxypyridine And Succinic Acid Derivatives And Their Nootropic Action In Alloxan Diabetes
59. Anti-Inflammatory Properties Of Noopept (Dipeptide Nootropic Agent Gvs-111)
60. Antioxidant Activity And Flavonoid Composition Of The New Nootropic Preparation Polynoophyt
61. Anti-Stress And Nootropic Activity Of Aqueous Extract Of Artocarpus Heterophyllus Fruit, And Y-Maze Test In Rodents.
62. Anti-Stress And Nootropic Activity Of Aqueous Extract Of Piper Longum Fruit, Estimated By Noninvasive Biomarkers And Y-Maze Test In Rodents
63. Anti-Stress And Nootropic Activity Of Drugs Affecting The Renin-Angiotensin System In Rats Based On Indirect Biochemical Evidence
64. Anti-Stress Anxiolytic And Nootropic Activity Of Nyctanthes Arbour Tritis Leaves
65. Anti-Stress, Nootropic And Anticonvulsant Potential Of Fruit Extracts Of Piper Longum L
66. Anxiolytic Activity Of Endogenous Nootropic Dipeptide Cycloprolylglycine In Elevated Plus-Maze Test
67. Anxiolytic Activity Of Piracetam, A Nootropic Agent, Following Subchronic
68. Anxiolytic Activity Of Piracetam, A Nootropic Agent, Following Subchronic Administration In Rodents.
69. Anxiolytic And Nootropic Activity Of Vetiveria Zizanioides Roots In Mice
70. Anxiolytic, Nootropic And Anticonvulsant Activity Of Hemidesmus Indicus In Laboratory Animals.
71. Application Of Nootropic Agents In Complex Treatment Of Patients With Concussion Of The Brain
72. Are Cb1 Receptor Antagonists Nootropic Or Cognitive Impairing Agents?
73. Assessing The Validity Of Danio Rerio As A Model Organism For Nootropic Research: The Effects Of Phenylpiracetam On Larval Zebrafish Behavior
74. Assessment Of Nootropic Activity Of Panchagavya Ghrita In Animal Models
75. Assessment Of Nootropic And Amnestic Activity Of Centrally Acting Agents
76. Assessment Of The Prevalence Of Nootropic Drugs By Elderly Patients In Geriatric Practice
77. Asthenic Syndrome In Clinical Course Of Acute Period Of Brain Concussion During Complex Treatment Using Nootropic Agents
78. Astrocytes Mediated The Nootropic And Neurotrophic Effects Of Sarsasapogenin-Aa13 Via Upregulating Brain-Derived Neurotrophic Factor
79. Avoidance Facilitation In Adult Mice By Prenatal Administration Of The Nootropic Drug Oxiracetam
80. Bacopa Monniera, A Reputed Nootropic Plant: An Overview
81. Bacopa Monnieri, A Nootropic Drug
82. Balance And The Nitric Oxide System In The Brain Tissue Of Rats Subjected To Experimental Acute Impairment Of Cerebral Blood Flow: The Therapeutic Effects Of Nootropic …
83. Bar-Pressing For Water Reward: Effects Of Nootropic Drugs And Peptides On Discrimination Learning In Rats.
84. Beekeeper’S Naturals Blxr Brain Fuel Review–Is Royal Jelly Even A Nootropic ?
85. Behavioral And Biochemical Evidences For Nootropic Activity Of Boldine In Young And Aged Mice
86. Behavioral And Electrophysiological Analysis Of The Choline-Positive Effect Of Nootropic Dipeptide Acylproline (Gvs-111)
87. Behavioral Pharmacological Studies Of Nootropic Candidates On The Central Dopaminergic Activity Rats
88. Beneficial Effect Of Sodium Thiosulfate Extends Beyond Myocardial Tissue In Isoproterenol Model Of Infarction: Implication For Nootropic Effects
89. Beyond Raw Chemistry Labs Nootropic Review: Does It Work?
90. Bioaccessibility Of The New Dipeptide Nootropic Drug Noopept
91. Biochemical Studies On The Nootropic Drug Oxiracetam In Brain
92. Biochemical Studies On The Nootropic Drug, Oxiracetam, In Brain
93. Biogenic Monoamine Uptake By Rat Brain Synaptosomes During Aging. Effects Of Nootropic Drugs
94. Blockade Of The Nootropic Action Of Piracetam-Like Nootropic s By Adrenalectomy: An Effect Of Dosage?
95. Blood Mononuclear Cells As Speculum Of Emotional Stress Analyzed By Synchrotron Infrared Spectroscopy And A Nootropic Drug
96. Brain Awake Review: Weak Stack With 1 Potent Nootropic
97. Brain Entry And Direct Central Pharmacological Effects Of The Nootropic Drug Oxiracetam
98. Brain Neurotransmitter Receptor Binding And Nootropic Studies On Indian Hypericum Perforatum Linn.
99. Brainflo Review–A Good Nootropic From Bioflourish
100. Can Nootropic Drugs Be Effective Against The Impact Of Ethanol Teratogenicity On Cognitive Performance?
101. Can The Pattern Of Neuropsychological Improvement Obtained With Cholinergic Drugs Be Used To Infer A Cholinergic Mechanism In Other Nootropic Drugs?
102. Cannabis-Induced Impairment Of Learning And Memory: Effect Of Different Nootropic Drugs
103. Cardiotoxicity Of The Nootropic Supplement, Phenylethylamine
104. Cell Line Toxicity Study And Pharmacological Screening Of Effective Nootropic Herbal Formulation In Rat
105. Central Depressant And Nootropic Effects Of Daytime Melatonin In Mice
106. Changes In Brain Biogenic Monoamines Induced By The Nootropic Drugs Adafenoxate And Meclofenoxate And By Citicholine (Experiments On Rats).
107. Changes In Sensitivity To Nootropic Drugs In Rats Exposed Pre-And Postnatally To Ethanol
108. Changes In The Indices Of Neuronal Functional Activity Under The Action Of Piracetam As A Possible Basis For Realizing The Effects Of Nootropic Agents
109. Changes In The Narrow-Band Components Of The Eeg Spectrum Under The Action Of Nootropic Drugs
110. Changes Of Dopamine Metabolism By Hypoxia And Effect Of Nootropic Drugs.
111. Changes Of High-Affinity Choline Uptake In The Hippocampus Of Old Rats After Long-Term Administration Of Two Nootropic Drugs (Tacrine And Ginkgo Biloba Extract)
112. Characterisation And Quality Assurance Studies On A Nootropic Agent And Ace Inhibitor Using Ftir Spectroscopy
113. Characteristics Of Antiischemic And Nootropic Properties Of Ademol In A Rat Model Of Acute Brain Ischemia
114. Characterization Of The Transcallosal Response In Aged Rats And Its Susceptibility To Nootropic Drugs
115. Chemistry, Pharmacology, And Clinical Efficacy Of The Chinese Nootropic Agent Huperzine A
116. Citicoline: Is This The Ultimate Natural Nootropic ?
117. Clinical And Psychometric Evaluation Of The Efficacy Of Nootropic Drugs: Characteristics Of Several Procedures.
118. Cognishield Review: Over-Priced And Over-Hyped Nootropic
119. Cognitive Improvement In Clinical Trials With Nootropic Drugs: When Can It Be Expected And How To Clarify Its Meaning
120. Cognitive Improvement In Clinical Trials With Nootropic Drugs: When Can It Be Expected And How To Clarify Its Meaning.
121. Cognitive Psychophysiology In Nootropic Drug Research: Effects Of Ginkgo Biloba On Event-Related Potentials (P300) In Age-Associated Memory Impairment
122. Comment On ‘Large-Scale Cognitive Gwas Meta-Analysis Reveals Tissue-Specific Neural Expression And Potential Nootropic Drug Targets’ By Lam Et Al.
123. Nootropic s”>Common Misconceptions: Nootropic Vs Cognitive Enhancers
124. Comparative Analysis Of Nootropic Means Of Consumption In Ukraine, Estonia And Norway
125. Comparative Assessment Of Nootropic Activity Of Yashtimadhu Choorna And Yashtimadhu Kshirapaka In Young And Aged Mice
126. Comparative Characteristics Of The Nootropic Action Of Phenibut And Phepyrone.
127. Comparative Efficiency Of Nootropic Drugs In Complex Treatment Of Patients With Remote Consequences Of Closed Craniocereberal Trauma
128. Comparative Experimental Research Into The Nootropic Action Of Procaine And Pyracetam.
129. Comparative Influence Of Nootropic Preparations On The Emetic Effect Of Morphine
130. Comparative Neurophysiological Study Of The Nootropic Drugs Piracetam And Centrophenoxine
131. Comparative Nootropic Effect Of Evolvulus Alsinoides And Convolvulus Pluricaulis
132. Comparative Studies On The Anticonvulsant Effectiveness Of Nootropic Drugs In Kindled Rats.
133. Comparative Studies On The Effects Of The Nootropic Drug Adafenoxate And Of The Cerebral Vasodilator Flunarizine On Arterial Smooth Muscles.
134. Comparative Studies On The Effects Of The Nootropic Drugs Adafenoxate, Meclofenoxate And Piracetam, And Of Citicholine On Scopolamine-Impaired Memory, Exploratory …
135. Comparative Study Of The Neuroprotective And Nootropic Activities Of The Carboxylate And Amide Forms Of The Hldf-6 Peptide In Animal Models Of Alzheimer’S Disease
136. Comparision Of Nootropic Effects Of Kaixinsan Prescription And Kaixinsan Without Poria Cocos (Schw.) Wolf To Alzheimer’S Mice Model
137. Comparison Of 1-(2-Naphthyloxymethylcarbonyl) Pyrrolidine, Pp-20/Dpj, Newly Synthesized Compound With The Nootropic Drug Piracetam In Normal And Aluminum …
138. Comparison Of Nootropic And Neuroprotective Features Of Aryl-Substituted Analogs Of Gamma-Aminobutyric Acid
139. Computational Analysis Of Theacrine, A Purported Nootropic And Energy-Enhancing Nutritional Supplement
140. Conceptual Considerations On The Influence Of Medhya Rasayana (Nootropic Drugs) In Cardiovascular Health
141. Conformation Of The Nootropic Agents 1-(4-Methoxybenzoyl)-5-Oxo-2-Pyrrolidinepropanoic Acid (Ci-933) And 4-Hydroxymethyl-1-Benzyl-Pyrrolidin-2-One (Web-1868) …
142. Conformational Transitions In The Nootropic Peptide Semax (Mehfpgp) And Its N-Terminal Modifications
143. Correction To: A Combination Of Nootropic Ingredients (Caf+) Is Not Better Than Caffeine In Improving Cognitive Functions
144. Correction: The Atypical Stimulant And Nootropic Modafinil Interacts With The Dopamine Transporter In A Different Manner Than Classical Cocaine-Like Inhibitors
145. Critical Issues In Nootropic Drug Research
146. Current Aspects Of The Search Of Effective Nootropic Drugs
147. Cyclic Gmp Mimicks Potentiation Effect Of The Nootropic Agent Vinpocetine On The High Threshold A-Current In The Mollusk Neurons
148. Delayed Nootropic Effects Of Arginine Vasopressin After Early Postnatal Chronic Administration To Albino Rat Pups
149. Design And Study Of Some Novel Ibuprofen Derivatives With Potential Nootropic And Neuroprotective Properties
150. Design, Synthesis And Nootropic Activity Of New Analogues Of Sunifiram And Sapunifiram, Two Potent Cognition-Enhancers
151. Design, Synthesis, And Preliminary Pharmacological Evaluation Of 1, 4-Diazabicyclo [4.3. 0] Nonan-9-Ones As A New Class Of Highly Potent Nootropic Agents
152. Designing A Formulation Of The Nootropic Drug Aniracetam Using 2-Hydroxypropyl-Β-Cyclodextrin Suitable For Parenteral Administration
153. Designing Nootropic Dipeptides Using An Evolutionary-Genetic Approach
154. Detection Of Nootropic Activity Indicated By Acute Inhibition Of Orientation Reaction
155. Development And Pharmacology Of Nootropic And Antidepressive Preparations Based On Eaa Receptor Ligands
156. Development Of New Drugs Of Plant Origin With Nootropic Action
157. Development Of New Drugs Of Plant Origin With Nootropic Action
158. Developmental Dyslexia And The Nootropic Concept
159. Different Susceptibilities Of Long-Term Potentiations In Ca3 And Ca1 Regions Of Guinea Pig Hippocampal Slices To Nootropic Drugs
160. Dipeptide Nootropic Agent Gvs-111 Prevents Accumulation Of The Lipid Peroxidation Products During Immobilization
161. Discussion On Tcm Mechanism Of Nootropic And Brain-Invigorating Chinese Traditional And Herbal Prescriptions And Drugs.
162. Disposition Of Ethimizol, A Nootropic Drug, In Rats And Mice.
163. Disposition Of Ethimizol, A Xanthine-Related Nootropic Drug, In Perfused Rat Liver And Isolated Hepatocytes.
164. Dissociation Of The Anti-Amnesic And Antihypoxic Effects Of Nootropic And Antihypoxic Preparations
165. Dm235 (Sunifiram): A Novel Nootropic With Potential As A Cognitive Enhancer
166. Dose-Dependent Pharmacokinetics Of A Xanthine-Related Nootropic Drug, Ethimizol, In Rats
167. Eeg Mapping In Dementia And Nootropic Drug Research
168. Effect Of A New Nootropic Agent, Cgs 5649B, On Cognition, Function, And Behavior In Dementia
169. Effect Of Anti-Epileptic, Nootropic Drugs On The Expression Of Erk2 And Ncam1 In The Hippocampus Changes On The Epileptic Rats With Cognitive Dysfunction
170. Effect Of Donepezil In Patients With Alzheimer’S Disease Previously Untreated Or Treated With Memantine Or Nootropic Agents In Germany: An Observational Study
171. Effect Of Drugs Of The Nootropic Class On Rat Behavior After Deprivation Of The Paradoxical Stage Of Sleep
172. Effect Of Idebenone And Various Nootropic Drugs On Lipid Peroxidation In Rat Brain Homogenate In The Presence Of Succinate
173. Effect Of Modification Of The N-Terminal Region Of Semax On The Expression Of Nootropic Effect Of Semax Analogs
174. Effect Of Natural Nootropic And Adaptogen Preparations On The Cortex Bioelectrical Activity In Rats
175. Effect Of Nootropic Agents On Brain Cholinergic Mechanisms
176. Effect Of Nootropic Agents On Impulse Activity Of Cerebral Cortex Neurons
177. Effect Of Nootropic Agents On Serum Biochemical Indices In Intellectually Deficient Children
178. Effect Of Nootropic Agents On The Brain Bioelectrical Activity And On The Indices Of Neuromediator Metabolism In The Acute Period Of Severe Craniocerebral Trauma
179. Effect Of Nootropic Agents On The Lowering Of The Spasm Threshold After A Single Ethanol Application
180. Effect Of Nootropic And Psycho-Stimulants On Children With Infantile Brain Damages.
181. Effect Of Nootropic Drugs On Age‐Dependent Changes In Transmitter Release
182. Effect Of Nootropic Drugs On Normal And Disturbed Sleep Of The Elderly: Controlled Studies With Pyridoxilate And Street Noise
183. Effect Of Nootropic Drugs On Restitution Of Biochemical Changes In Cns Tissue After Paradoxical Sleep Deprivation In Rats.
184. Effect Of Nootropic Drugs On The Dopamine Release And Dopamine Uptake In Structures Of The Rat Striatum
185. Effect Of Nootropic Solcoseryl® On Kainic Acid-Induced Excitotoxic Brain Injury
186. Effect Of Piper Longum On Urinary Metabolites And Its Correlation With Nootropic Activity In Rat Models
187. Effect Of Piracetam, A Nootropic Agent, On Discrimination Learning Deficits Induced By Parental Undernutrition And Environmental Impoverishment In Young Rats.
188. Effect Of Piracetam, A Nootropic Agent, On Experimental Gastric Ulcers In Rat.
189. Effect Of Repeated Application Of Nootropic Drugs On Sleep In Rats.
190. Effect Of Scopolamine And Nootropic Drugs On Rewarded Alternation In A T-Maze
191. Effect Of The Combination Of The Benzodiazepine Tranquilizer Medazepam And The Nootropic Agent Meclofenoxate On The Activity Of Rat Brain Muscarinic Receptors
192. Effect Of The Nootropic Agent Cerebrolysin In Cerebral Ischemia In Rats With Varying Behavioral Reactions In The Open Field Test
193. Effect Of The Nootropic Drug Oxiracetam On Field Potentials Of Rat Hippocampal Slices.
194. Effect Of The Novel Dipeptide Nootropic Agent Noopept And Its Metabolite Cyclo-L-Prolylglycine On The Transcallosal Evoked Potential In The Rat Brain
195. Effect Of The Novel Nootropic And Neuroprotective Dipeptide Noopept On The Streptozotocin-Induced Model Of Sporadic Alzheimer Disease In Rats
196. Effectiveness Of Nootropic Drugs With Cholinergic Activity In Treatment Of Cognitive Deficit: A Review
197. Effects Of A Cholinergic Nootropic (Web 1881 Fu) On Event-Related Potentials Recorded In Incidental And Intentional Memory Tasks
198. Effects Of Aniracetam, A Nootropic Drug, In Senile Dementia
199. Effects Of Heptapeptide Of The Tuftsin Group With Nootropic Components Of Action And Piracetam On Formation Of Escape Reaction In Normal Conditions And In Conflict …
200. Effects Of Nebracetam (Web 1881 Fu), A Novel Nootropic , As A M1-Muscarinic Agonist
201. Effects Of Nefiracetam, A Novel Pyrrolidone‐Type Nootropic Agent, On The Amygdala‐Kindled Seizures In Rats
202. Effects Of Nicotinic Cholinoreceptor Ligands And Nootropic Drugs On The Spontaneous Exploratory Activity In A Labyrinth In Mice
203. Effects Of Nootropic Agents On The Performing Of Active Two-Way Avoidance Tasks In Young And Old Rats.
204. Effects Of Nootropic Agents On Visual Functions And Lacrimal Antioxidative Activity In Patients With Primary Open-Angle Glaucoma
205. Effects Of Nootropic Drugs For Demented Patients—A Study Using Loreta
206. Effects Of Nootropic Drugs In A Scopolamine-Induced Amnesia Model In Mice
207. Effects Of Nootropic Drugs Of Pentylenetetrazol Kindling In Rats
208. Effects Of Nootropic Drugs On Behavior Of Balb/C And C57Bl/6 Mice In The Exploratory Cross-Maze Test
209. Effects Of Nootropic Drugs On Brain Cholinergic And Dopaminergic Transmission.
210. Effects Of Nootropic Drugs On Dopaminergic Systems In The Cns.
211. Effects Of Nootropic Drugs On Hippocampal And Cortical Bdnf Levels In Mice With Different Exploratory Behavior Efficacy
212. Effects Of Nootropic Drugs On Some Behavioural And Biochemical Changes After Early Postnatal Hypoxia In The Rat.
213. Effects Of Nootropic Drugs On The Sleep-Waking Pattern Of The Rat.
214. Effects Of Red Ginseng Saponins And Nootropic Drugs On Impaired Acquisition Of Ethanol-Treated Rats In Passive Avoidance Performance
215. Effects Of The Nootropic Agents Adafenoxate And Meclofenoxate On Brain Biogenic Monoamines In Aged Rats.
216. Effects Of The Nootropic Agents Adafenoxate, Meclofenoxate And The Acetylcholine Precursor Citicholine On The Brain Muscarinic Receptors (Experiments On Rats).
217. Effects Of The Nootropic Awd 52-39 On The Blood-Brain Transfer Of Leucine, Choline And Glucose In Rats After 14-D Exposure To Ethanol.
218. Effects Of The Nootropic Drug Nefiracetam On The Gabaa Receptor-Channel Complex In Dorsal Root Ganglion Neurons
219. Effects Of The Nootropic Nefiracetam On Rat Hippocampal Gaba Release
220. Effects Of Various Nootropic Candidates On The Impaired Acquisition Of Ethanol-Treated Rats In Step-Through Test
221. Effects Of Web 1881 Fu, A Novel Nootropic , On Cholinergic And Adrenergic Receptors In The Rat Brain: Action On M1-Muscarinic Receptors
222. Efficacy Of A Nootropic Spearmint Extract On Reactive Agility: A Randomized, Double-Blind, Placebo-Controlled, Parallel Trial
223. Efficacy Of The Peptidergic Nootropic Drug Cerebrolysin In Patients With Senile Dementia Of The Alzheimer Type (Sdat)
224. Electrographic Correlates Of The Antiamnestic Action Of Nootropic Agents Following Deprivation Of The Paradoxical Sleep Phase
225. Electrophysiological Correlates Of Efficacy Of Nootropic Drugs In The Treatment Of Consequences Of Traumatic Brain Injury In Adolescents
226. Electrophysiological Evaluation Of The Demented State And The Nootropic Effect Of Ta-0910 By” Automated Fluctuation Analysis” Of The High-Frequency Eeg–Relation …
227. Endolumbal Nootropic -Ozone Therapy In Complex Treatment Of Patients With Complicated Spinal Injury In Acute Period
228. Endolumbar Nootropic -Ozone Therapy In Multimodality Treatment Of Patients With A Complicated Spinal Injury At Its Acute Period
229. Enhancement Of Adenosine‐Induced Relaxant Responses Of The Guinea‐Pig Isolated Taenia Coli And Aortae By A Novel Nootropic Agent By‐1949: Comparison With …
230. Enhancement Of Neuronal Calcium Channel Currents By The Nootropic Agent, Nefiracetam (Dm-9384), In Ng108-15 Cells
231. Enhancement Of Nootropic Effect Of Duloxetine And Bupropion By Caffeine In Mice
232. Establishing Natural Nootropic s: Recent Molecular Enhancement Influenced By Natural Nootropic
233. Estimation Of Being And Perspective Of Demand On Nootropic Drugs
234. Estimation Of The Antioxidant Effect Of The Nootropic Dipeptide Noopept On The Model Of Fe2+-Induced Chemiluminescence Of Lipoproteins Of Human Serum In Vitro
235. Ethical Underpinning And Implications Of “Nootropic ” Concept
236. Ethylene Bis-Imidazoles Are Highly Potent And Selective Activators For Isozymes Va And Vii Of Carbonic Anhydrase, With A Potential Nootropic Effect
237. Evaluation Of Antibacterial, Antioxidant And Nootropic Activities Of Tiliacora Racemosa Colebr. Leaves: In Vitro And In Vivo Approach
238. Evaluation Of Anticonvulsant And Nootropic Effect Of Ondansetron In Mice
239. Evaluation Of Geriatric Patients With Special Reference To Clinical Trials Of Socalled Nootropic Drugs
240. Evaluation Of Green Tea For Its Nootropic Activity
241. Evaluation Of Nootropic Activity Of Aegle Marmelos Extract Using Different Experimental Models In Rats
242. Evaluation Of Nootropic Activity Of Carica Papaya In Mice
243. Evaluation Of Nootropic Activity Of Cressa Cretica In Scopolamine-Induced Memory Impairment In Mice
244. Evaluation Of Nootropic Activity Of Curcuma Longa Leaves In Diazepam And Scopolamine-Induced Amnesic Mice And Rats
245. Evaluation Of Nootropic Activity Of Ethanolic And Aqueous Root Extracts Of Adhatoda Vasica Nees In Rodents
246. Evaluation Of Nootropic Activity Of Ethanolic Extract Of Ardisia Blatteri Using Different Experimental Models In Rats
247. Evaluation Of Nootropic Activity Of Limonia Acidissima Against Scopolamine-Induced Amnesia On Rats
248. Evaluation Of Nootropic Activity Of Salvia Officinalis L. Extract Using Different Experimental Models In Rats. J
249. Evaluation Of Nootropic Activity Of Sida Cordifolia In Mice
250. Evaluation Of Nootropic Activity Of Slimaluma, An Enriched Phytochemical Composition Of Caralluma Fimbriata In Mice
251. Evaluation Of Nootropic Activity Of Smrithi: A Polyherbal Formulation
252. Evaluation Of Nootropic Activity Of Two Marketed Drugs Of Bacopa Monnieri In Scopolamine Induced Amnesic Models
253. Evaluation Of Nootropic Activity Of Vigna Mungo Linn. On Scopolamine Induced Cognitive Dysfunction In Mice
254. Evaluation Of Nootropic Activity Potential Of Krill Oil In Diazepam Induced Amnesic Mice
255. Evaluation Of Nootropic Activity Potential Of Krill Oil In Diazepam Induced Amnesic Mice
256. Evaluation Of Nootropic And Neuroprotective Effects Of Low Dose Aspirin In Rats
257. Evaluation Of Nootropic Drugs Using Event-Related Potential (P300) In Monkeys
258. Evaluation Of Nootropic Effect Of Argyreia Speciosa In Mice
259. Evaluation Of Nootropic Effects Of Aqueous Extract Of Tridax Procumbens Linn On Cognitive Functions In Mice
260. Evaluation Of Nootropic Effects Of Galantamine And Sildenafil As A Combination In Mice
261. Evaluation Of Nootropic Potential Of Green Peas In Mice
262. Evaluation Of Nootropic Potential Of Ocimum Sanctum Linn. In Mice
263. Evaluation Of Polyherbal Preparation Divya Medha Vati For Nootropic , Anxiolytic And Anticholinesterase Activity
264. Evaluation Of The Anti-Amyloidogenic Potential Of Nootropic Herbal Extracts In Vitro
265. Evaluation Of The Nootropic Activity Of Arabica Coffee Pulp Extract (Coffea Arabica)
266. Evaluation Of The Nootropic Effect Of Mebikar In Clinical Practice
267. Evalution Of Nootropic And Anti-Nociceptive Activity Of Green Tea In Comparison With Medha Rasayana
268. Evidence Based Anti-Dementing Activity Of Saraswata Ghrita” A Nootropic Compound From Ayurveda
269. Evidence For Nootropic Effect Of Br-16A (Mentat [R]), A Herbal Psychotropic Preparation, In Mice
270. Evidence Pharmacy: Inclusion To The Schemes Of Pharmacotherapy Of The Drug Addicted Patients With Opioid Dependence Of The Nootropic Drugs
271. Examination Of Lesions In The Urinary Bladder And Kidney Of Dogs Induced By Nefiracetam, A New Nootropic Agent
272. Examining The Nootropic Effects Of A Special Extract Of Bacopa Monniera On Human Cognitive Functioning: 90 Day Double‐Blind Placebo‐Controlled Randomized Trial
273. Excitatory Amino Acids And Neuronal Plasticity: Modulation Of Ampa Receptors As A Novel Substrate For The Action Of Nootropic Drugs.
274. Experience In The Application Of Pramistar, A New Nootropic Preparation, In The Treatment Of Memory Disorders In Patients With Cerebrovascular Pathology
275. Experimental And Clinical Evaluation Of Nootropic Activity Of Bacopa Monniera Linn.(Brahmi)
276. Experimental Studies On The Effects Of Nootropic Mixture (Yizhiheji) In Improving Studying & Memorizing And Fighting Aging Of Alzheimer Diseased Rats
277. Exploring The Nootropic Effect Of Juniperus Recurva Extract: Possible Involvement Of Acetylcholinesterase Inhibition
278. Facilitation Of Calcium-Dependent Cholinergic Function By Ucb L059, A New “Second Generation” Nootropic Agent
279. Facilitation Of Evoked Transcallosal Responses By Nootropic Agents
280. Factors Influencing The Prescribing Of Nootropic Drugs. Results Of A Representative Inquiry In Lower Saxony
281. Fasoracetam–An Anxiety-Reducing Nootropic
282. Fast And” Slow” Components Of Psychotropic Activity Of The Drugs With Nootropic Effects
283. Fast Thin-Layer Densitometric Determination Of The Nootropic Piracetam In Biological Material
284. Force Factor Forebrain Review: Low Budget Nootropic
285. Form Edge Review–An Excellent Nootropic Stack
286. Formulation And Standardization Of Medhya Rasayana–A Novel Ayurvedic Compound Nootropic Drug
287. Gamma-Aminobutyric Acid Metabolism In The Rat Brain After Administration Of Nootropic Agents
288. Genius Joy Review: The First “Feel-Good” Nootropic ?
289. Geriatric Pharmacology. Pharmacokinetics And Pharmacodynamics In The Elderly. Problems With Geriatric And Nootropic Drugs
290. Ginkgo Biloba Is Not A Smart Drug: An Updated Systematic Review Of Randomised Clinical Trials Testing The Nootropic Effects Of G. Biloba Extracts In Healthy People
291. Global Dimensional Complexity Of Multi-Channel Eeg Indicates Change Of Human Brain Functional State After A Single Dose Of A Nootropic Drug
292. Green Tea: Is It Actually A Potent Nootropic ?
293. Hedychium Spicatum: Evaluation Of Its Nootropic Effect In Mice
294. Hemidesmus Indicus: Evaluation Of Its Nootropic Effect In Mice
295. Hemidesmus Indicus: Evaluation Of Its Nootropic Effect In Mice.
296. Herbal Nootropic Agents.
297. Hidden Nature Neuro Focus Review: Is It A Good Nootropic ?
298. High Field Nmr Techniques And Molecular Modelling Study Of The Inclusion Complexes Of The Nootropic Drug Tenilsetam (Cas-997) In Cyclodextrins
299. High-Performance Liquid Chromatographic Determination Of A New Nootropic , N-(2, 6-Dimethylphenyl)-2-(2-Oxo-1-Pyrrolidinyl) Acetamide, In Human Serum And Urine
300. How Can You Avoid Inferior Nootropic Supplements
301. Hunter Focus Review–Is It Really The Best Nootropic Stack?
302. Huperzine A, A Nootropic Agent, Inhibits Fast Transient Potassium Current In Rat Dissociated Hippocampal Neurons
303. Huperzine A, A Nootropic Alkaloid, Inhibits N-Methyl-D-Aspartate-Induced Current In Rat Dissociated Hippocampal Neurons
304. Hypericum Perforatum As A Nootropic Drug: Enhancement Of Retrieval Memory Of A Passive Avoidance Conditioning Paradigm In Mice
305. Hypoglycemic, Antistress, Anxiolytic, And Nootropic Activity Of Roots Of Rubia Cordifolia Linn
306. Hypoxia And Memory. Specific Features Of Nootropic Agents Effects And Their Use
307. I15 Nootropic Effect And Action Mechanisms Of Ginsenoside Rg1, A Smart Drug Candidate
308. Identification And Evaluation Of A Panel Of Ginsenosides From Different Red Ginseng Extracts With Nootropic Effect
309. Identifying Nootropic Drug Targets Via Large-Scale Cognitive Gwas And Transcriptomics
310. Immunostimulant, Cerebroprotective & Nootropic Activities Of Andrographis Paniculata Leaves Extract In Normal & Type 2 Diabetic Rats
311. Impact Of A Purported Nootropic Supplementation On Measures Of Mood, Stress, And Marksmanship Performance In Us Active Duty Soldiers
312. Impact Of Nootropic Supplementation On Measures Of Marksmanship Performance In Active Duty Soldiers
313. Impaired Plasticity Of Hippocampal Synaptic Transmission In Rats Exposed To Prenatal Hypoxia Is Normalized By Treatment With Nootropic Dipeptides
314. Impairment Of Contextual Fear Conditioning In Rats By Group I Mglurs: Reversal By The Nootropic Nefiracetam
315. Impairment Of Learning And Memory In Rats Neonatally Injected With 6-Hydroxydopamine (6-Ohda). Effects Of Nootropic Drugs
316. Impairment Of Learning And Memory In Shuttle Box-Trained Rats Neonatally Injected With 6-Hydroxydopamine. Effects Of Nootropic Drugs.
317. Improvement Of Avoidance Acquisition By The Nootropic Drug Oxiracetam In Mice.
318. Improving Mental Performance In An Athletic Population With The Use Of Ārepa®, A Blackcurrant Based Nootropic Drink: A Randomized Control Trial
319. In Silico And In Vitro Evaluation Of Brain Penetration Properties Of Selected Nootropic Agents
320. In Silico Evaluation Of The Nootropic Potential Of Anacardic Acid Isolated From The Bark Of Cashew Nut
321. In Silico Target Identification Of Nootropic Bioactive Compounds From Ayurvedic Herbs
322. In Vitro And In Vivo Effect Of The Nootropic Agent Adafenoxate On The 5-Ht1 Sites In Different Rat Brain Structures
323. Influence Of Antiarrhythmic And Nootropic Drugs On Model And Biological Membranes
324. Influence Of Nootropic Agents And Hyperbaric Oxygenation In The Treatment Of Acute Poisonings With Halogenated Hydrocarbons
325. Influence Of Nootropic And Antidepressive Drugs On Open Field And Running Wheel Behavior In Spontaneously High And Low Active Mice
326. Influence Of Nootropic Drugs On Apomorphine-Induced Stereotyped Behaviour In Rats.
327. Influence Of Nootropic Drugs On Drinking Behaviour In Ethanol-Preferring Mice And Ethanol-Induced Increase Of Seizure Susceptibility.
328. Influence Of Nootropic Drugs On The Age-Dependent Potassium-Coupling Of Transmitter Release.
329. Influence Of Nootropic Drugs On The Learning-And Memory-Impairing Effect Of Diethyldithiocarbamate In Albino Rats.
330. Influence Of Nootropic Drugs On The Memory-Impairing Effect Of Clonidine In Albino Rats.
331. Influence Of Nootropic Drugs On The Memory-Impairing Effect Of Diethyldithiocarbamate And Clonidine In” Step Down” Passive Avoidance In Albino Rats.
332. Influence Of Nootropic Drugs On The Stimulus‐Release Relationship Of Dopaminergic Structures
333. Influence Of Ring Size On The Cognition-Enhancing Activity Of Dm235 And Mn19, Two Potent Nootropic Drugs
334. Influence On Memory By A New Nootropic Compound
335. Interaction Between Nootropic Drugs And Methamphetamine On Avoidance Acquisition But Not On Locomotor Activity In Mice
336. Investigation Of Nootropic Drugs (Pyramem And Orocetam) For Their Teratogenic Effect
337. Investigation Of The Effects Of Hydration And Amphiphilic Properties Of Nootropic Drugs Of Piracetam And Pramiracetam
338. Investigations On The Binding Properties Of The Nootropic Agent Pyroglutamic Acid.
339. Involvement Of Gaba In Nootropic And Anxiolytic Activity Of Saponins Of Albizzia Lebbeck Leaves
340. Iq² Nootropic Review
341. Isolation Of Two Ochrobactrum Sp. Strains Capable Of Degrading The Nootropic Drugâ Piracetam
342. Isolation Of Two Ochrobactrum Sp. Strains Capable Of Degrading The Nootropic Drug—Piracetam
343. Isolation, Identification, And Nootropic Activity Of Compounds In Alfredia Cernua Chloroform Extract
344. Just Say “Nootropic ”: The Effects Of Nicotine On Memory And Learning
345. Large-Scale Cognitive Gwas Meta-Analysis Reveals Tissue-Specific Neural Expression And Potential Nootropic Drug Targets
346. Large-Scale Cognitive Gwas Meta-Analysis Reveals Tissue-Specific Neural Expression And Potential Nootropic Drug Targets.
347. Late Consequences Of Neonatal Short-Term Inhibition Of Protein Synthesis In Adult Rats And The Effects Of Nootropic Drugs: A Biochemical And Behavioural Study.
348. Learning And Memory Impairment In Albino Rats After Potassium Ethylxanthogenate. Effects Of Nootropic Agents.
349. Literature Review: Caffeine As Mental Stimulant And Nootropic
350. Ltp Deficiency In Adult Rats Prenatally Exposed To Ethanol Or Hypoxia And Its Correction By Postnatal Treatment With Nootropic Compounds
351. Lumonol Wisdom–Nootropic Stack For Seniors?
352. Mechanism Of Action Of Tetrahydro-N, N-Dimethyl-5, 5-Diphenyl-3-Furanemethanamine, A Putative Nootropic , Anti-Epileptic And Antidepressant Compound
353. Mechanism Of Nootropic Digam Action In Hypofunction Of Brain Dopaminergic System
354. Medicinal Plants With Nootropic Effect: A Review
355. Memory Effects Of A Group Of Newly-Synthesized Pyrrolidine Derivatives With Putative Nootropic Effect.
356. Memory Effects Of The Combination Of Medazepam With Nootropic Agents.
357. Memory Impairment Induced By Combined Disturbance Of Noradrenergic And Dopaminergic Neurotransmissions: Effects Of Nootropic Drugs.
358. Memory Retrieval Deficits: Alleviation By Etiracetam, A Nootropic Drug
359. Mental Retardation Among Children With Cerebral Palsy As Observed In Nepal With A Small Trial With Nootropic (Modafinil)
360. Meta-Analysis: The Efficacy Of Nootropic Agent Cerebrolysin In The Treatment Of Alzheimer’S Disease
361. Methodological Approach To The Clinical Evaluation Of Nootropic Drugs
362. Methodological Approaches To The Design Of Solid Dosage Forms Of Nootropic Action On The Basis Of Plant Raw Materials
363. Methylazoxymethanol Microencephaly In Rats: Neurochemical Characterization And Behavioral Studies With The Nootropic Oxiracetam.
364. Mind Lab Pro Review: Should You Buy This Nootropic ?%% Sep%%%% Sitename%%
365. Mind Lab Pro Review: The Complete Package Nootropic ?
366. Modern Approach To Development Of Nootropic Agents Based On Γ-Aminobutyric Acid
367. Modern Problems Of The Pharmacology Of Nootropic Agents: The Status And Outlook
368. Modulating Effect Of The Nootropic Drug, Piracetam On Stress‐And Subsequent Morphine‐Induced Prolactin Secretion In Male Rats
369. Modulation Of Ampa Receptor Desensitization By Nootropic Drugs And Endogenous Proteins
370. Modulation Of Long-Term Memory By Delayed Administration Of The Amide Of L-Pyroglutamyl-D-Alanine, A Nootropic Agent, In Spaced And Massed Training In Rats
371. Modulation Of The Effects On Learning And Memory Of Nootropic Drugs And Central Stimulants When Applied Together.
372. Modulation Of The Long-Term Memory By Delayed Administration Of The Nootropic Agent L-Pyroglutamyl-D-Alaninamide During Spaced And Massed Training Of Rats
373. Modulation Of The Neuronal Nicotinic Acetylcholine Receptor-Channel By The Nootropic Drug Nefiracetam
374. Molecular Determinants For Drug-Receptor Interactions: 1. Solid-State Structure And Conformation Of The Novel Nootropic Agent 2-Pyrrolidone-N-Acetamide: X-Ray …
375. Molecular Determinants For Drug—Receptor Interactions: Part 2. An Ab Initio Molecular Orbital And Dipole Moment Study Of The Novel Nootropic Agent Piracetam (2 …
376. Molecular Docking, Spectroscopic Studies And Quantum Calculations On Nootropic Drug
377. Molecular Modeling Of Β‐Cyclodextrin Complexes With Nootropic Drugs
378. Molecular Simplification Of 1, 4-Diazabicyclo [4.3. 0] Nonan-9-Ones Gives Piperazine Derivatives That Maintain High Nootropic Activity
379. Molecular-Biochemical Mechanisms Of The Effects Of Nootropic Agents
380. Monitoring The Internet For Nootropic Substances Available To Australian Consumers
381. Moringa Oleifera Supplemented Diet Modulates Nootropic -Related Biomolecules In The Brain Of Stz-Induced Diabetic Rats Treated With Acarbose
382. Multiple Mechanisms Underlying Nootropic Drug-Induced Enhancement Of Neuronal Responses Mediated By Activation Of Glutamate Nmda-Type Receptors
383. Naftidrofuryl Oxalate, Nootropic Effects On The Scopolamine-And The Basal Forebrain Lesion-Induced Amnesia In Rats
384. Natrol Cognium Review: Totally Over-Hyped Nootropic
385. Natural Product Synthesis Via Cyclobutanes: Part I, Asymmetric Synthesis Of (+)-Byssochlamic Acid, Part Ii, An Approach To The Nootropic Agent Huperzine A
386. Negative Regulation Of Opioid Receptor‐G Protein‐Ca2+ Channel Pathway By The Nootropic Nefiracetam
387. Nerve Growth Factor And Nootropic Drug Cerebrolysin But Not Fibroblast Growth Factor Can Reduce Spatial Memory Impairment Elicited By Fimbria-Fornix Transection: Short …
388. Neu Nootropic Boost–Does It Work?
389. Neurochemical Assessments Of The Actions Of Novel Agents Having Nootropic And Anxiolytic Potential: The Measurement In Brain …
390. Neurocognitive Effect Of Nootropic Drug Brahmi (Bacopa Monnieri) In Alzheimer’S Disease
391. Neurogenix-Fast Acting Liquid Nootropic
392. Neurohacker Collective Qualia Mind Review–Great Nootropic Despite Flaws
393. Neuronal Ca2+ Channels And Nicotinic Ach Receptors As Functional Targets Of The Nootropic Nefiracetam
394. Neuropathobiology Of Senile Dementia And Mechanism Of Action Of Nootropic Drugs
395. Neuropharmacological Review Of The Nootropic Herb Bacopa Monnieri
396. Neurophysiological Analysis Of The Correction By Nootropic Substances Of Disorders In The Bioelectric Activity Of The Brain In Animals During Chronic Administration Of …
397. Neurophysiological Analysis Of The Effects Of Nooglutil As Opposed To Known Nootropic Drugs
398. Neuroprotective And Nootropic Actions Of A Novel Cyclized Dipeptide After Controlled Cortical Impact Injury In Mice
399. Neuroprotective And Nootropic Activity Of Carica Papaya Seeds On Diabetes Induced Cognitive Decline In Rats
400. Neuroprotective And Nootropic Activity Of Clitorea Ternatea Linn.(Fabaceae) Leaves On Diabetes Induced Cognitive Decline In Experimental Animals
401. Neuroprotective And Nootropic Drug Noopept Rescues Α-Synuclein Amyloid Cytotoxicity
402. Neuroprotective Effect Of Kapakh, Representative Of New Nootropic Class Non-Anticholinesterase Organophosphoric Compounds
403. Neuroprotective Effects Of A New Nootropic Agent Mitochondrin-2
404. Neuroprotective Properties Of Nootropic Dipeptide Gvs-111 In In Vitro Oxygen-Glucose Deprivation, Glutamate Toxicity And Oxidative Stress
405. Neuropsychopharmacological Effects Of The Ayurvedic Nootropic Bacopa Monniera Linn.(Brahmi)
406. New (−)− Cytisine Derivatives With Nootropic Activity
407. New Aspects Of The Neurophysiological Mechanism Of The Action Of Nootropic Preparations
408. New Nootropic Preparation From Blood Plasma (Adement): Lack Of Therapeutic Influence On Drosophila Neurodegenerative Model
409. New Pharmacological Perspectives On Nootropic Drugs
410. New Trends In The Search For Nootropic Preparations
411. Nmda Component In The Effects Of Piracetam And New Nootropic Peptide Gvs-111 On The Neocortical And Hippocampal Eeg In Conscious Rats
412. Nmda-Independent Long-Term Depression Of Synaptic Transmission In The Hippocampus: Mechanisms Of Induction And Effects Of Nootropic Drugs
413. Non-Linear Dose Effect Relationship In Anxiolytic And Nootropic Activity Of Lithium Carbonate And Nardostachys Jatamansi In Rats
414. Nonopioid And Neuropathy-Specific Analgesic Action Of The Nootropic Drug Nefiracetam In Mice
415. Noocube Review⋆ Nootropic Supplement⋆ Does It Work?
416. Nootropic (Medhya) Effect Of Bhāvita Śaṇkhapuṣpī Tablets: A Clinical Appraisal
417. Nootropic Action Of Proline-Based Topological Analogs Of Piracetam
418. Nootropic Action Of Some Antihypertensive Drugs: Computer Predicting And Experimental Testing
419. Nootropic Activity Of A Novel (-)-Cytisine Derivative (3Ar, 4S, 8S, 12R, 12As, 12Br)-10-Methyl-2-Phenyloctahydro-1H-4, 12A-Etheno-8, 12-Methanopyrrolo [3′, 4′: 3, 4] …
420. Nootropic Activity Of Acetaminophen Against Colchicine Induced Cognitive Impairment In Rats
421. Nootropic Activity Of Ajuga Bracteosa Wall On Scopolamine Induced Memory Deficits In Swiss Albino Mice
422. Nootropic Activity Of Albizzia Lebbeck In Mice
423. Nootropic Activity Of Bacomind, An Enriched Phytochemical Composition From Bacopa Monnieri
424. Nootropic Activity Of Butanolic Extract Passiflora Incarnata Leaves
425. Nootropic Activity Of Calyces Of Hibiscus Sabdariffa Linn
426. Nootropic Activity Of Caralluma Fimbriata Extract In Mice
427. Nootropic Activity Of Celastrus Paniculatus Seed
428. Nootropic Activity Of Crataeva Nurvala Buch-Ham Against Scopolamine Induced Cognitive Impairment
429. Nootropic Activity Of Ethanolic Extract Of Alangium Salvifolium Leaves On Scopolamine Mouse Model Of Alzheimer’S Disease
430. Nootropic Activity Of Extracts From Wild And Cultivated Alfredia Cernua
431. Nootropic Activity Of Glycinergic Derivatives In Relation To Their Dualistic Effects On Cerebral Monoamines
432. Nootropic Activity Of Hydroalcoholic Extract Of Trapa Bispinosa
433. Nootropic Activity Of L-33–A Polyherbal Formulation
434. Nootropic Activity Of Lipid‐Based Extract Of Bacopa Monniera Linn. Compared With Traditional Preparation And Extracts
435. Nootropic Activity Of Lipid-Based Extract Of Bacopa Monniera Linn. Compared With Traditional Preparation And Extracts.
436. Nootropic Activity Of Moringa Oleifera Leaves
437. Nootropic Activity Of N-(2-Acetylaminoethyl) Glycolurils
438. Nootropic Activity Of Nicotinamide And Its Structural Analogs
439. Nootropic Activity Of Ocimum Gratissimum In Streptozotocin Induced Amnesia
440. Nootropic Activity Of Some Quinazoline Amides
441. Nootropic Activity Of Tuber Extract Of Pueraria Tuberosa (Roxb)
442. Nootropic Activity Of Ureidoacids And Thiohydantoins
443. Nootropic Activity Of Vitis Vinifera Juice In Normal And Memory-Impaired Mice Using Spatial Learning And Recognition Memory Paradigms
444. Nootropic Activity Of Zingiber Officinale In Albino Mice: A Behavioral And Neurochemical Approach.
445. Nootropic _Affects_Global_Dimensional_Complexity_of.1105.aspx”>Nootropic Affects Global Dimensional Complexity Of Multichannel Eeg
446. Nootropic Agent Vinpocetine Blocks Delayed Rectified Potassium Currents More Strongly Than High-Threshold Calcium Currents
447. Nootropic Agents Enhance The Recruitment Of Fast Gabaa Inhibition In Rat Neocortex
448. Nootropic Agents In The Complex Treatment Of Patients With Traumatic Epilepsy
449. Nootropic Agents Stimulate Neurogenesis: Brain Cells, Inc.: Wo2007104035
450. Nootropic And Adaptogenic Effect Of Combined Use Of Cortexin With Polyunsaturated Fatty Acids Concentrate Under Experimental Dislipidemia
451. Nootropic And Analgesic Effects Of Semax Following Different Routes Of Administration
452. Nootropic And Anti-Alzheimer’S Actions Of Medicinal Plants: Molecular Insight Into Therapeutic Potential To Alleviate Alzheimer’S Neuropathology
453. Nootropic And Anti-Amnestic Effect Of Ppa On Scopolamine-Induced Cognitive Impairment In Mice
454. Nootropic And Antiamnestic Effects Of Tenoten (Pediatric Formulation) In Immature Rat Pups
455. Nootropic And Antihypoxic Properties Of Novel Derivatives Of 1, 2-Dihydro-3H-1, 4-Benzodiazepin-2-One
456. Nootropic And Anti-Stress Effects Of Rice Bran Oil In Male Rats
457. Nootropic And Anxiolytic Activity Of Saponins Of Albizzia Lebbeck Leaves
458. Nootropic And Anxiolytic Properties Of Endogenous Ligands Of Benzodiazepine Receptors And Their Structural Analogs
459. Nootropic And Hypophagic Effects Following Long Term Intake Of Almonds (Prunus Amygdalus) In Rats
460. Nootropic And Neuroprotective Effects Of Dichrocephala Integrifolia On Scopolamine Mouse Model Of Alzheimer’S Disease
461. Nootropic And Neuroprotective Effects Of Ethanol Extract Of Vateria Indica L Bark On Scopolamine-Induced Cognitive Deficit In Mice
462. Nootropic And Vasotropic Pharmacotherapy In Neurology: Combination Of Drugs Or Combinational Effect?
463. Nootropic And Vasotropic Pharmacotherapy In Neurology: Combination Of Drugs Or Combinational Effect?
464. Nootropic Candidates Inhibit Head-Twitches Induced By Mescaline In Mice
465. Nootropic Compound L-Pyroglutamyl-D-Alanine-Amide Restores Hippocampal Long-Term Potentiation Impaired By Exposure To Ethanol In Rats
466. Nootropic Correction Of Disturbances In Learning And Memory Caused By Superhigh Frequency Electromagnetic Radiation
467. Nootropic Dipeptide Noopept Enhances Inhibitory Synaptic Transmission In The Hippocampus
468. Nootropic Dipeptide, Noopept Can Modulate Hyperalgesia By Effecting On Spinal Microglia Dependent Brain Derived Neurotropic Factor (Bdnf) And Pro-Bdnf …
469. Nootropic Dipeptide, Noopept Can Modulate Hyperalgesia By Effecting On Spinal Microglia Dependent Brain Derived Neurotropic Factor (Bdnf) And Pro-Bdnf …
470. Nootropic Drug Evaluation For General Practice
471. Nootropic Drug Modulation Of Neuronal Nicotinic Acetylcholine Receptors In Rat Cortical Neurons
472. Nootropic Drugs
473. Nootropic Drugs
474. Nootropic Drugs
475. Nootropic Drugs And Aging.
476. Nootropic Drugs And Brain Cholinergic Mechanisms
477. Nootropic Drugs And Their Action Mechanisms In Relation To The Neuropathobiology Of Senile Dementia. I. Neurotransmission Disorders In The Brain
478. Nootropic Drugs Glia Signalling Neurorobotics/Prosthetics Brain Imaging Technology Uses And Limitations/Fmri, Eeg Ect… Brain Training?
479. Nootropic Drugs Have Different Effects On Kindling-Induced Learning Deficits In Rats
480. Nootropic Drugs In Alzheimer Disease Treatment. New Pharmacological Strategies
481. Nootropic Drugs In Alzheimer’S Disease: Symptomatic Treatment With Pramiracetam
482. Nootropic Drugs Positively Modulate Α‐Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid‐Sensitive Glutamate Receptors In Neuronal Cultures
483. Nootropic Drugs Potentiate Nerve Cell Responses Evoked By Nmda-Glutamate Receptor Activation
484. Nootropic Drugs Reduce Immobility In Behavioural Despair Test In Mice.
485. Nootropic Drugs: Animal Models For Studying Effects On Cognition
486. Nootropic Drugs: Evaluation On The Safety And Efficacy
487. Nootropic Drugs: Methylphenidate, Modafinil And Piracetam–Population Use Trends, Occurrence In The Environment, Ecotoxicity And Removal Methods–A Review
488. Nootropic Drugs: The Gap Between Preclinical And Clinical Results
489. Nootropic Effect Of Berberine In Colchicines Induced Experimental Alzheimer’S Disease Model: Effect On Cholinergic Neurotransmission
490. Nootropic Effect Of Br-16A (Mentat), A Psychotropic Herbal Formulation, On Cognitive Deficits Induced By Prenatal Undernutrition, Postnatal Environmental …
491. Nootropic Effect Of Combined Application Of Means From Baikal Seal Fat And Cortexin At Cerebral Ischemia
492. Nootropic Effect Of Complex Phytoremedy «Noophyt» Extract
493. Nootropic Effect Of Dangsheng, Codonopsis Pilosula (Franch.) Nannf [J]
494. Nootropic Effect Of Dengyin Nao Tong Capsule On Aging Mice
495. Nootropic Effect Of Ecuadorian Linseed Oil And Powder (Linum Usitatissimum) On Mus Musculus Mice
496. Nootropic Effect Of Forsythiaside On A Novel Complex Mouse Model Of Alzheimer Disease And Its Mechanism [J]
497. Nootropic Effect Of Ginsenoside Rg1 And Its Metabolites And Its Signaling Pathway
498. Nootropic Effect Of Hypocholesterolemic Drugs In Scopolamine Induced Amnesic Rats
499. Nootropic Effect Of Ipomoea Aquatic Forsk In Rat Hippocampus
500. Nootropic Effect Of Meadowsweet (Filipendula Vulgaris) Extracts
501. Nootropic Effect Of Neferine On Aluminium Chloride–Induced Alzheimer’S Disease In Experimental Models
502. Nootropic Effect Of Nicotine On Carbon Monoxide (Co)-Induced Delayed Amnesia In Mice
503. Nootropic Effects Of Ace Inhibitors In Mice
504. Nootropic Effects Of Filipendula Vulgaris Moench Water Extract Fractions
505. Nootropic Effects Of New Drug Curdlipid C6
506. Nootropic Effects Of Psychedelic And Addictive Substances
507. Nootropic Effects Of Synthetic Flavonoid Derivatives On Scopolamine Induced Memory Impairment In Mice Via Cholinesterase Inhibition And Antioxidant System.
508. Nootropic Efficacy Of Satvavajaya Chikitsa And Ayurvedic Drug Therapy: A Comparative Clinical Exposition
509. Nootropic Herbal Formulations For The Treatment Of Alzheimer’S Disease: In Vivo Pharmacological Assay And Molecular Docking Studies
510. Nootropic Herbs (Medhya Rasayana) In Ayurveda: An Update
511. Nootropic Investigation: Vinpocetine
512. Nootropic Medicinal Plants: Therapeutic Alternatives For Alzheimer’S Disease
513. Nootropic Medicinal Plants; Evaluating Potent Formulation By Novelestic High Throughput Pharmacological Screening (Htps) Method
514. Nootropic Nanocomplex With Enhanced Blood-Brain Barrier Permeability For Treatment Of Traumatic Brain Injury-Associated Neurodegeneration
515. Nootropic Nefiracetam Inhibits Proconvulsant Action Of Peripheral‐Type Benzodiazepines In Epileptic Mutant El Mice
516. Nootropic Pharmacotherapy And Its Role In Solving The Problems Of Women Health
517. Nootropic Potential Of Alternanthera Sessilis And Clerodendrum Infortunatum Leaves On Mice
518. Nootropic Potential Of Ashwagandha Leaves: Beyond Traditional Root Extracts
519. Nootropic Potential Of Bauhinia Variegata: A Systematic Study On Murine Model
520. Nootropic Potential Of Murraya Koenigii Leaves In Rats
521. Nootropic Potential Of Silver Nanoparticles Of Boerhaavia Diffusa And Its Ethanolic Extract In High Fat Diet Model Of Dementia In Rats
522. Nootropic Preparations, The Achievements And New Problems
523. Nootropic Properties Of Gamma-Aminobutyric Acid Derivatives
524. Nootropic Signal Transduction Of Ginsenoside Rg1
525. Nootropic Stacks: The What, The Why And The How
526. Nootropic Studies Of Ethanolic Extract Of Mimosa Pudica Linn. In Albino Wistar Rats
527. Nootropic Substances Enhance The N-Methyl-D-Aspartate-Induced Short-Term Potentiation Of Synaptic Transmission In Rat Hippocampal Slices
528. Nootropic Supplements For Cognitive Improvement How To Prevent Alzheimer’S Disease
529. Nootropic Treatment And Combined Therapy In Age-Associated Memory Impairment
530. Nootropic Α7 Nicotinic Receptor Allosteric Modulator Derived From Gabaa Receptor Modulators
531. Nootropic , Anxiolytic And Cns-Depressant Studies On Different Plant Sources Of Shankhpushpi
532. Nootropic , Neuroprotective And Neurotrophic Effects Of Phloretin In Scopolamine Induced Amnesia In Mice
533. Normalization Of The Adaptive Avoidance Reaction In Rats Using Substances With Nootropic Activity
534. Novel Nootropic Dipeptide Noopept Increases Inhibitory Synaptic Transmission In Ca1 Pyramidal Cells
535. Novel Nootropic Drug Sunifiram Enhances Hippocampal Synaptic Efficacy Via Glycine‐Binding Site Of N‐Methyl‐D‐Aspartate Receptor
536. Novel Nootropic Drug Sunifiram Improves Cognitive Deficits Via Cam Kinase Ii And Protein Kinase C Activation In Olfactory Bulbectomized Mice
537. Novel Small Peptides With Neuroprotective And Nootropic Properties
538. Novel Validated Analytical Method Based On Potentiometric Transduction For The Determination Of Citicoline Psychostimulant/Nootropic Agent
539. Oasis Herbals Neurovault Review–Scam Nootropic !
540. On Some Mechanisms Of Antihypoxic Actions Of Nootropic Drugs.
541. Organix Labs Focuspower Review–Does This Nootropic Actually Work?
542. Original Article Nootropic Medicinal Plants; Evaluating Potent Formulation By Novelestic High Throughput Pharmacological Screening (Htps) Method
543. Original Nootropic Drug Noopept Prevents Memory Deficit In Rats With Muscarinic And Nicotinic Receptor Blockade
544. Outline For The Evaluation Of Nootropic Drugs
545. Over-The-Counter Stimulant, Depressant, And Nootropic Use By Veterinary Students
546. Over-The-Counter Stimulant, Depressant, And Nootropic Use In Veterinary Medical Students
547. Participation Of Dihydropyridine-Sensitive Calcium Channels In Psychotropic Effects Of Nootropic Drugs
548. Pass Assisted Prediction And Pharmacological Evaluation Of Novel Nicotinic Analogs For Nootropic Activity In Mice
549. Peculiarities Of Protein Metabolism At Administration To Prenatal Alcoholized Rats Of Aza-15-Crown-5 Ether Derivative With Nootropic Activity.
550. Peptide Analogs Of Pyracetam As Ligands For Hypothetical Nootropic Receptors
551. Peptidergic Nootropic Therapy In Cerebral Palsy Associated With Epilepsy
552. Performance Enhancement At The Cost Of Potential Brain Plasticity: Neural Ramifications Of Nootropic Drugs In The Healthy Developing Brain
553. Performance Lab Mind Review–Simple, Effective, Potent–Great Nootropic
554. Pharmacoeconomical Aspects Of Using Of Antianxious And Nootropic Preparations In Complex Treatment Of Patients With …
555. Pharmacokinetic And‐Dynamic Studies In Elderlies With A Potential Antihypoxidotic/Nootropic Drug Tenilsetam Utilizing Pharmaco‐Eeg And Psychometry
556. Pharmacokinetic Properties Of An Innovative Nootropic Agent Based On A Derivative Of 3, 7-Diazabicyclo [3.3. 1] Nonane
557. Pharmacokinetics And Brain Entry Of Alaptide, A Novel Nootropic Agent, In Mice, Rats And Rabbits
558. Pharmacokinetics Of A Nootropic Agent, Bmy-21502, And Its Metabolites In Beagle Dogs
559. Pharmacokinetics Of New Nootropic Acylprolyldipeptide And Its Penetration Across The Blood-Brain Barrier After Oral Administration
560. Pharmacokinetics Of The Potential Nootropic Drug Of-5858
561. Pharmacological Exploration Of Nootropic Activity Of Some Indigenous Medicinal Plants
562. Pharmacological Properties Of Digam—A New Potential Nootropic Drug
563. Pharmacological Validation Of In-Silico Guided Novel Nootropic Potential Of Achyranthes Aspera L.
564. Phenibut (Β‐Phenyl‐Gaba): A Tranquilizer And Nootropic Drug
565. Phytochemical Analysis, Antioxidant, Antistress, And Nootropic Activities Of Aqueous And Methanolic Seed Extracts Of
566. Phytochemical Analysis, Antioxidant, Antistress, And Nootropic Activities Of Aqueous And Methanolic Seed Extracts Of Ladies Finger (Abelmoschus Esculentus L.) …
567. Phytochemical Screening And Invivo Nootropic Evaluation Of Carissacarandus Linn. Roots
568. Phytochemicals Analysis Of Formulated Ayurveda Rasayana Using Nootropic Herbs
569. Phytopharmacology Of Indian Nootropic Convolvulus Pluricaulis
570. Piperazines As Nootropic Agents: New Derivatives Of The Potent Cognition-Enhancer Dm235 Carrying Hydrophilic Substituents
571. Piracetam-Induced Changes In The Functional Activity Of Neurons As A Possible Mechanism For The Effects Of Nootropic Agents
572. Piracetam-The Original Nootropic
573. Plants With Nootropic Activity: A Review
574. Platelet Hyperreactivity And Antiaggregatory Properties Of Nootropic Drugs Under Conditions Of Alloxan-Induced Diabetes In Rats
575. Platelet-Activating Factor: A New Target Site For The Development Of Nootropic Agents
576. Possibilities Of Application Of Nootropic Drugs In Treatment Of Epilepsy (Literature Review)
577. Possibilities Of Correction For Vascular Cognitive Impairments Using Preparations With Combined Nootropic And Vasoactive Action
578. Possible Role Of Nitric Oxide In The Nootropic And Antiamnesic Effects Of Neurosteroids On Aging-And Dizocilpine-Induced Learning Impairment
579. Post‐Stroke Dementia: Nootropic Drug Modulation Of Neuronal Nicotinic Acetylcholine Receptors
580. Potential Nootropic Agents, 4-Alkoxy-2-(1-Piperazinyl) Quinazoline Derivatives
581. Potential Nootropic Agents: Synthesis Of A Series Of (2-Oxo-1-Pyrrolidinyl) Acetic Acid Piperazides
582. Potential Nootropic Agents: Synthesis Of Some (2-Oxo-1-Pyrrolidinyl) Acetamides And Some Related Compounds
583. Potential Nootropic Agents: Synthesis Of Some 1, 4-Disubstituted 2-Oxopyrrolidines And Some Related Compounds
584. Potential Of Peptidergic Nootropic Therapy In Developmental Dysphasia In Children
585. Potentiation Of N-Methyl-D-Aspartate-Induced Currents By The Nootropic Drug Nefiracetam In Rat Cortical Neurons
586. Potentiation Of Nootropic Activity Of Egcg Loaded Nanosuspension By Piperine In Swiss Male Albino Mice
587. Potentiation Of Α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (Ampa)-Selective Glutamate Receptor Function By A Nootropic Drug, Idebenone
588. Power On Nootropic Review–Suspicious Proprietary Blend!
589. Practicable And Valid Approach To Evaluate The Efficacy Of Nootropic Drugs By Means Of Rating Scales
590. Pramiracetam: A Nootropic Agent With Improved Efficacy In Patients With Senile Or Presenile Cognitive Impairment
591. Preliminary Study On Nootropic Effect Of Vanda Tesselata Roots
592. Premium Vitality Nootropic Review–Complete Waste Of Time!
593. Preparation And Screening Of Swarnaprashana For Nootropic Activity
594. Presynaptic Facilitation By The New Nootropic Drug Nebracetam, Of Ganglionic Muscarinic Transmission In The Dog Cardiac Sympathetic Ganglion.
595. Progress In The Study Of Nootropic Mechanisms Of Panax Ginseng
596. Progress On The Study Of The Effects Of Aging And Nootropic Drugs On Membrane Fluidity Of Neurons
597. Proline-Based Topologic Pyracetam Analogs And Their Nootropic Activity
598. Proline-Containing Dipeptide Gvs-111 Retains Nootropic Activity After Oral Administration
599. NProof Of Therapeutical Effectiveness Of Nootropic And Vasoactive Drugs: Advances In Clinical And Experimental Nicergoline Research
600. Prosopis Cineraria: A Potential Nootropic Agent
601. Prospective New Nootropic Substances Of The Group Of Amides Of P-Chlorophenoxyacetic And Propionic Acids
602. Protection From Phenytoin-Induced Cognitive Deficit By Bacopa Monniera, A Reputed Indian Nootropic Plant
603. Protection Of Cell Proteins Against Free-Radical Attack By Nootropic Drugs: Scavenger Effect Of Pyritinol Confirmed By Electron Spin Resonance Spectroscopy
604. Psychopharmacological Properties Of Peptides With Nootropic Type Of Action
605. Psychophysiological Research In Psychiatry And Neuropsychopharmacology. Ii. The Investigation Of Antihypoxidotic/Nootropic Drugs (Tenilsetam And Co-Dergocrine …
606. Psychostimulant And Nootropic Effect Of Major And Trace Element Composition
607. Psychotropic Properties Of Nootropic Substances With A Cholinergic Action Component In Single And Long-Term Use
608. Pyritinol-The Antioxidant, Immune-Enhancing, Anti-Rheumatoid Arthritis Nootropic
609. Qsar-Modeling Of Bis-Azaaromatic Quaternary Ammonium Organic Salts With Nootropic Activity
610. Qsar-Modeling Of Bis-Azaaromatic Quaternary Ammonium Organic Salts With Nootropic Activity
611. Qualia Review–A Revolutionary Nootropic Stack?
612. Quantitative Evaluation Of The Anxiolytic And Nootropic Effects Of Potassium Orotate In A Wide Range Of Doses
613. Radioelectroencephalographic Characterization Of Tenilsetam (Cas 997), A Putative Nootropic Compound, In The Freely Behaving Rat
614. Rapid Inhibition Of Exploratory Movements As A Test Of Nootropic Activity
615. Regeneration Potential And Major Metabolite Analysis In Nootropic Plant-Bacopa Monnieri (L.) Pennell
616. Regulatory System Of Brain Chromatin In Nootropic Action
617. Repurposing Of The Nootropic Drug Vinpocetine As An Analgesic And Anti-Inflammatory Agent: Evidence In A Mouse Model Of Superoxide Anion-Triggered …
618. Research Article Phytochemical Analysis, Antioxidant, Antistress, And Nootropic Activities Of Aqueous And Methanolic Seed Extracts Of Ladies Finger …
619. Results Of Treatment With A Broad-Acting Nootropic Preparation On Chronic Diffuse Cerebral Disturbances
620. Retracted:Nootropic ‐Like Effect Of Ashwagandha (Withania Somnifera L.) In Mice
621. Reversal Of Scopolamine-Induced Amnesia And Alterations In Energy Metabolism By The Nootropic Piracetam: Implications Regarding Identification Of Brain Structures …
622. Rhodiola Rosea: Nootropic Powerhouse?
623. Role Of Functional State Of Neuronal Mitochondria Of Cerebral Cortex In Mechanisms Of Nootropic Activity Of Neuroprotectors In Rats With Alloxan Hyperglycemia
624. Role Of Medhya Rasayana (Nootropic Herbs) In Present Scenario: An Ayurvedic Overview
625. Role Of Metabotropic Glutamate Receptor Subclasses In Modulation Of Adenylyl Cyclase Activity By A Nootropic Ns-105
626. S‐52, A Novel Nootropic Compound, Protects Against Β‐Amyloid Induced Neuronal Injury By Attenuating Mitochondrial Dysfunction
627. Safety And Tolerability Of The Anxiolytic And Nootropic Drug Phenibut: A Systematic Review Of Clinical Trials And Case Reports
628. Scopolamine-Induced Amnesia Model: A Possible Anticholinergic Mechanism With Reversibility With Statins And Nootropic Agents
629. Screening And Personalizing Nootropic Drugs And Cognitive Modulator Regimens In Silico
630. Screening Of Aqueous And Ethanolic Extracts Of Aerial Parts Of Alternanthera Sessilis Linn. R. Br. Ex. Dc For Nootropic Activity
631. Screening Of Black Spruce Oilfor Nootropic Activity In Rats
632. Screening Of Taxillus Tomentosus Ethanolic Extract For Nootropic And Antistress Activity In Rats
633. Search For A Perfect Nootropic Supplement Combination-Can We Increase Human Intelligence By Nutritional Supplements
634. Search For Nootropic Substances Based On Molecular Docking Of Methanepyrido[1,2-A][1, 5]Diazocin[(-)-Cytisine] Derivatives To The Active Center Of The Nicotinic …
635. Semax, An Acth (4-10) Analogue With Nootropic Properties, Activates Dopaminergic And Serotoninergic Brain Systems In Rodents
636. Senile Dementia Of The Alzheimer Type Treated With Aniracetam: A New Nootropic Agent
637. Shodhana Decreases Nootropic Activity Of Semecarpus Anacardium
638. Shortening Of N1 And P3 Latencies In Event‐Related Potentials Observed Coincidentally With Clinical Improvement During Nootropic Medication In A Demented …
639. Single‐And Multiple‐Dose Pharmacokinetics Of Nefiracetam, A New Nootropic Agent, In Healthy Volunteers
640. Smartervitamins Brain Support Review: Should You Buy This Nootropic ?
641. Solid-State Structure And Conformation Of The Nootropic Agent 4-Hydroxy-2-Oxo-1-Pyrrolidineacetamide: X-Ray And Theoretical Self-Consistant Field Molecular Orbital (Scf …
642. Solid-State Structure And Solution Conformation Of The Nootropic Agent N [2-(N, N-Diisopropylamino) Ethyl]-2-Oxo-1-Pyrrolidinacetamide Sulphate. X-Ray And …
643. Some Clinical Studies With Piracetam–A “Nootropic ” Substance
644. Some Considerations Of Different Modes Of Action Of Nootropic Drugs
645. Space-Oriented Eeg Segmentation Reveals Changes In Brain Electric Field Maps Under The Influence Of A Nootropic Drug
646. Specific Modulation Of Social Memory In Rats By Cholinomimetic And Nootropic Drugs, By Benzodiazepine Inverse Agonists, But Not By Psychostimulants
647. Spect Monitoring Of Improved Cerebral Blood Flow During Long-Term Treatment Of Elderly Patients With Nootropic Drugs
648. Spectral And Frequency Analysis Of The Central Eeg Activity In Parkinson’S Disease Patients With Alzheimer’S Disease: The Development During Nootropic Therapy
649. Spiro-[4H-Pyrroio[1,2-A][1,4]Benzodiazepine-4,4′-Piperidine] Derivatives As Potential Nootropic Agents: A Simple One-Pot Synthesis
650. Steady State Visually Evoked Potential (Ssvep) Phase Change As An Index Of Spatial Working Memory Task Performance: The Influence Of Nootropic Supplementation
651. Structure Of Acetylcholinesterase Complexed With The Nootropic Alkaloid,(–)-Huperzine A
652. Studies Of The Lipophilic Components Of A Dense Extract Of The Herb Alfredia Cernua And Its Nootropic Properties
653. Studies On Nootropic Activity And Mechanism Of Emodin-8-O-# Beta#-D-Glucopyranoside
654. Studies On Nootropic Activity And Mechanism Of Emodin-8-O-?-D-Glucopyranoside
655. Studies On Nootropic Activity Of Ramipril And Losartan On Scopolamine-Induced Amnesia In Rats
656. Studies On Nootropic Activity Of Roots Of Tylophora Indica In Mice
657. Studies On Nootropic Effects Of Various Extracts Of Gmelina Arborea And Cayratia Trifolia
658. Studies On The Anti-Aging And Nootropic Effects Of Ginsenoside Rg_1 And Its Mechanisms Of Actions [J]
659. Studies On The Anti-Aging And Nootropic Effects Of Ginsenoside Rg1 And Its Mechanisms Of Actions
660. Studies On The Metabolism And The Toxicological Analysis Of The Nootropic Drug Fipexide In Rat Urine Using Gas Chromatography–Mass Spectrometry
661. Studies On The Nootropic And Anti-Amnestic And Anxiolytic-Like Effects Of Gjd-Ppa In Mice
662. Study Of The Effects Of Nootropic Agents On The Adrenergic Neurotransmission In Smooth Muscles Of Young And Old Animals.
663. Study Of The Protective Effects Of Nootropic Agents Against Neuronal Damage Induced By Amyloid-Beta (Fragment 25–35) In Cultured Hippocampal Neurons
664. Study On Nootropic Activity Of Aegle Marmelos L Fruits
665. Study On Nootropic Activity Of Root Extracts Of Adhatoda Vasica Nees In Mice And Rats
666. Study On Nootropic Effects Of Mechanical Of 5-Hydroxynicotinic Acid And L-Glutamic Acid And D-, L-Isomers Of Ampasse
667. Study On The Nootropic Mechanism Of (-) Clausenamide-Influence On The Formation Of Synapses In Mouse Brain
668. Study On The Nootropic Mechanism Of Ginsenoside Rb1 And Rg1–Influence On Mouse Brain Development
669. Study On The Nootropic Mechanism Of Ginsenosides
670. Studying Specific Effects Of Nootropic Drugs On Glutamate Receptors In The Rat Brain
671. Studying The Nootropic Effects Of Betamecil
672. Substituted Piperazines As Nootropic Agents: 2-Or 3-Phenyl Derivatives Structurally Related To The Cognition-Enhancer Dm235
673. Synchronization In The Functioning Of Neurons Of The New Cortex And Hippocampus During Learning Before And After The Administration Of Nootropic Agents And Narcotics
674. Synthesis And Biological Evaluation Of 3, 7-Diazabicyclo [4.3. 0] Nonan-8-Ones As Potential Nootropic And Analgesic Drugs
675. Synthesis And Biological Evaluation Of Schiff’S Bases And 2-Azetidinones Of Isonocotinyl Hydrazone As Potential Antidepressant And Nootropic Agents
676. Synthesis And Inhibitory Activity Of Acylpeptidyl-Prolinal Derivatives Toward Post-Proline Cleaving Enzyme As Nootropic Agents
677. Synthesis And Nootropic Acitivity Of N-Acyl-4-Phenyel-2-Pyrrolidones
678. Synthesis And Nootropic Activity Of 2-Oxo-1-Pyrrolidinesulfonic Acid Derivatives.
679. Synthesis And Nootropic Activity Of New 3-Amino-12-N-Methylcytisine Derivatives
680. Synthesis And Nootropic Activity Of Oxamoylamino Acids
681. Synthesis And Nootropic Activity Of Pyrrolidino [1, 2-A] Diazacycloalkanes
682. Synthesis And Nootropic Activity Of Some 2,3‐Dihydro‐1H‐Isoindol‐1‐One Derivatives Structurally Related With Piracetam
683. Synthesis And Specific Nootropic Activity Of (–)-Cytisine Derivatives With Carbamide And Thiocarbamide Moieties In Their Structure
684. Synthesis Of 4-Phenylpyrrolidone Derivatives With Anticonvulsant And Nootropic Activity
685. Synthesis Of The 3-Hydroxy Oxiracetam Enantiomers, Potential Nootropic Drugs
686. Synthesis Of The Benzenoid Analogue Of The Chinese Nootropic Agent Huperzine A
687. Synthesis Of The Nootropic Drug S-Stereoisomer Of Oxiracetam
688. Synthetic Acth Analogue Semax Displays Nootropic ‐Like Activity In Humans
689. The “Nootropic ” Approach To The Pharmacology Of The Integrative Activity Of The Brain (1973)
690. The “Nootropic ” Approach To The Pharmacology Of The Integrative Activity Of The Brain 1, 2
691. The Acute Nootropic Effects Of Ginkgo Biloba In Healthy Older Human Subjects: A Preliminary Investigation
692. The Antiamnestic Effect Of Nootropic Substances In Rats
693. The Antihypoxic Effect Of Ethymisole: A Comparison With Other Nootropic Drugs.
694. The Atypical Stimulant And Nootropic Modafinil Interacts With The Dopamine Transporter In A Different Manner Than
695. The Atypical Stimulant And Nootropic Modafinil Interacts With The Dopamine Transporter In A Different Manner Than Classical Cocaine-Like Inhibitors
696. The Bioavailability Of Tableted Drug Forms Of The New Russian Nootropic Preparation Nooglutil In Rabbits
697. The Brain Functions By Bitter (Vernonia Amygdalina) And Water Bitter (Struchium Sparganophora) Leaves Extracts: Comparison Of Phenolic Constituents Versus Nootropic …
698. The Conjuncture Analysis Of The Range Of Nootropic Drugs Registered In Ukraine
699. The Development Of The Physicochemical Characteristics Of The New Original Nootropic Substance Tst-9
700. The Dose-Dependency Of The Effects Of 2 Methyl 3 (Phenylaminomethyl)-1H-Quinolin-4 One–A Promising Antidepressant With Nootropic Properties
701. The Eaa-Ergic Modulation Of The Brain Dopaminergic System As A Basis For Creating New Nootropic Agents With Stress-Protective Activity
702. The Effect Of Combined Therapy Of Exercise And Nootropic Agent On Cognitive Function In Focal Cerebral Infarction Rat Model
703. The Effect Of Enzyme Induction And Inhibition On The Disposition Of The Xanthine-Related Nootropic Drug Ethimizol In Perfused Liver And Hepatocytes Of Rats.
704. The Effect Of Nootropic Agents On Brain Mitochondrial Function In The Dynamics Of Craniocerebral Trauma From The Age Aspect
705. The Effect Of Nootropic Agents On The Biochemical Parameters Of The Blood Serum From Children With Intellectual Deficit.
706. The Effect Of Preparations With Nootropic Action When Used Long-Term On The Brain Bioelectrical Activity In Rats
707. The Effect Of Substances With Nootropic Activity On Oxidative Phosphorylation In Brain Mitochondria In Acute Craniocerebral Trauma
708. The Effect Of The New Nootropic Dipeptide Gvs-111 In Different Functional Disorders Of The Escape Reaction
709. The Effects Of Anti-Dementia And Nootropic Treatments On The Mortality Of Patients With Dementia: A Population-Based Cohort Study In Taiwan
710. The Effects Of Nootropic Drugs On Metabotropic Glutamate Receptors In The Brains Of Balb/C And C57Bl/6 Mice
711. The Effects Of Scopolamine And The Nootropic Drug Phenotropil On Rat Brain Neurotransmitter Receptors During Testing Of The Conditioned Passive Avoidance Task
712. The Establishment Of Computer-Based Auto-Controlling And Image-Analysing Processing System Of Circle Water-Maze For Studying Nootropic Drugs From Traditonal …
713. The Fluorescence And Resonance Rayleigh Scattering Spectra Study On The Interactions Of Palladium (Ii)-Nootropic Chelate With Congo Red And Their Analytical …
714. The Functional Importance Of Cerebral Noradrenergic Processes For The Activating Action Of Nootropic Drugs In The Behavioural Despair Test In Mice.
715. The Gabab Receptor Antagonist Cgp 36 742 And The Nootropic Oxiracetam Facilitate The Formation Of Long-Term Memory
716. The Influence Of Piracetam On Behavior And Brain Receptors In C57Bl/6 And Balb/C Mice: Nootropic And Anxiolytic Effects
717. The Influence Of The Semax Nootropic Agent On The Behavioral Signs Of The Withdrawal Syndrome And On The Craving For Alcohol In White Rats And The Determination Of Its …
718. The Interaction Of Nootropic Drugs With Anticonvulsants.
719. The Neuroleptic And Nootropic Treatment Of Ergotamine-And Analgesic-Induced Headaches
720. The New Nootropic Mechanism Of Action Of The Modern Antidepressant Rolipram On Cognitive Functions
721. The Nootropic Agent Vinpocetine Blocks The Delayed Rectifier Potassium Channel More Strongly Than The High-Conductance Calcium Channel
722. The Nootropic Alkaloid,(–)-Huperzine A
723. The Nootropic And Analgesic Effects Of Semax Given Via Different Routes
724. The Nootropic And Anticholinesterase Activities Of Clitoria Ternatea Linn. Root Extract: Potential Treatment For Cognitive Decline
725. The Nootropic And Anxiolytic Properties Of Different Doses Of Piracetam
726. The Nootropic And Neuroprotective Proline-Containing Dipeptide Noopept Restores Spatial Memory And Increases Immunoreactivity To Amyloid In An Alzheimer’S Disease …
727. The Nootropic Components Of Hovenia Dulcis.
728. The Nootropic Compound Bmy-21502 Improves Spatial Learning Ability In Brain Injured Rats
729. The Nootropic Concept And Dyslexia
730. The Nootropic Concept And Its Prospective Implications
731. The Nootropic Correction Of Disorders In Learning And Memory Processes Induced By Extreme Exposures
732. The Nootropic Drug Vinpocetine Inhibits Veratridine-Induced [Ca2+] I Increase In Rat Hippocampal Ca1 Pyramidal Cells
733. The Nootropic Drug Vinpocetine Modulates Different Types Of Potassium Currents In Molluscan Neurons
734. The Nootropic Drug Α-Glyceryl-Phosphoryl-Ethanolamine Exerts Neuroprotective Effects In Human Hippocampal Cells
735. The Nootropic Drugs Piracetam And Oxiracetam Do Not Reduce Anxiety In Mice During Elevated-X-Maze Testing
736. The Nootropic Properties Of Ginseng Saponin Rb1 Are Linked To Effects On Anxiety
737. The Nootropic Properties Of The Tetrapeptide Acetyl-(D-Lys)-Lys-Arg-Arg-Amide (Kk-1) On The Model Of Scopolamine-Induced Alzheimer’S Disease In Rats
738. The Novel Dipeptide Translocator Protein Ligand, Referred To As Gd-23, Exerts Anxiolytic And Nootropic Activities
739. The Novel Nootropic Compound Dm232 (Unifiram) Ameliorates Memory Impairment In Mice And Rats
740. The Original Nootropic And Neuroprotective Drug Noopept Potentiates The Anticonvulsant Activity Of Valproate In Mice
741. The Original Novel Nootropic And Neuroprotective Agent Noopept
742. The Pharmacokinetic Characteristics Of The New Psychotropic Preparation With Nootropic Action Onk-10 In The Progeny Of Alcoholized Animals
743. The Pharmacokinetics Of The Dipeptide Analog Of Piracetam With Nootropic Activity Gvs-111 And Of Its Basic Metabolites
744. The Pharmacology Of Nootropic Drugs: Geropsychiatric Implications
745. The Placebo Effect Of A Nootropic And Verbal Placebo In Enhancing The Cognitive Ability Of Children Focusing On Memory Recall.
746. The Problem Of Nootropic Pharmacotherapy Safety In Neurological Practice
747. The Research Progress Of A Single Traditional Chinese Medicine’S Mechanism About Nootropic Effect [J]
748. The Significance Of The Antihypoxic Properties Of Etimizol In Its Nootropic Action
749. The Synthesis Of (4-Sup 3 H) Oxiracetam-A Novel Nootropic Agent
750. The Synthesis Of [4‐3H]Oxiracetam ‐ A Novel Nootropic Agent
751. The Treatment With Antihypertensive And Nootropic Preparations Of Hypertension Patients Working Under Neuroemotional Stress
752. Nootropic -brain-supplements-and-brain-power/”>The Truth About Nootropic Brain Supplements And Brain Power
753. The Use Of A Scopolamine Model To Study The Nootropic Effects Of Tenilsetam (Cas 997) In Man.
754. The Use Of A Scopolamine Model To Study The Potential Nootropic Effects Of Aniracetam And Piracetam In Healthy Volunteers
755. The Use Of The Hplc Method For The Quantitative Determination Of A Peptide Analog Of Piracetam With Nootropic Activity And Its Main Metabolites
756. The Use Of Xenopus Oocytes To Evaluate Drugs Affecting Brain Ca2+ Channels: Effects Of Bifemelane And Several Nootropic Agents
757. The Usefulness Of Event-Related Negativity In Demonstrating The Therapeutic Effects Of Nootropic Drugs Using Cerebrolysin As An Example
758. Therapeutic Efficacy Of Nootropic Drugs In Alzheimer’S Disease And Age Related Cognitive Dysfunction
759. Therapeutic Efficacy Of Nootropic Drugs—A Discussion Of Clinical Phase Iii Studies With Nimodipine As A Model
760. Thinq Smart Review–Good Nootropic But Far From The Best
761. Three-Dimensional Pharmacophoric Pattern Search Using Compass: Nootropic Agents
762. Top 3 Instant Nootropic Drinks
763. Top 3 Nootropic Stimulants
764. Traditional Chinese Nootropic Medicine Radix Polygalae And Its Active Constituent Onjisaponin B Reduce Β-Amyloid Production And Improve Cognitive …
765. Treatment Of Experimental Destruction Of The Duodenum With Preparations With Nootropic Action
766. Treatment Of Raynaud Syndromes With Piracetam (Nootropil R), Nootropic And Aniplatelet Agent
767. Treatment With Nootropic Drugs
768. Trophic Effects Of Nootropic Peptide Preparations Cerebrolysin And Semax On Cultured Rat Pheochromocytoma
769. Ucb 11056, A New Potential Nootropic Drug, Amplifies Induced Cyclic Amp Formation In Rat Brain Tissue
770. Utmost Me Neuro Focus Plus Review–Lackluster Nootropic
771. Varsity Medical Ethics Debate 2015: Should Nootropic Drugs Be Available Under Prescription On The Nhs?
772. Vinpocetine: Nootropic Effects On Scopolamine-Induced And Hypoxia-Induced Retrieval Deficits Of A Step-Through Passive Avoidance Response In Rats
773. Why Bacopa Is My Favorite Nootropic
774. Why Bacopa Is My Favorite Nootropic Published 2017-03-03 18: 44: 35
775. X-Ray And 1H-Nmr Spectroscopic Studies Of The Structures And Conformations Of The New Nootropic Agents Ru-35929, Ru-47010 And Ru-35965
776. X-Ray, Nmr And Theoretical Studies Of The Structure And Conformation Of The Nootropic Agent Tenilsetam
777. X‐Ray, Nmr, And Theoretical Studies Of The Nootropic Agent Bmy‐21502, A Pyrrolidinone Derivative
778. Zinc-A Trace-Element As A Nootropic Agent
779. Zingiber Officinale: Evaulation Of Its Nootropic Effect In Mice